24Serious

Rohan Kanhai

Ask VT AI

View News Summary

Under Armour's weak Q1 sales and tariff pressures lead to a plunge in its stock price.
Trump administration plans major IPOs for Fannie Mae and Freddie Mac, potentially raising $30 billion and valuing the companies at $500 billion.
Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making its stock a top performer.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Under Armour's weak Q1 sales and tariff pressures lead to a plunge in its stock price.
Trump administration plans major IPOs for Fannie Mae and Freddie Mac, potentially raising $30 billion and valuing the companies at $500 billion.
Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making its stock a top performer.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Rohan Kanhai